Drugs / C752
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06210243 | Dec 2023 → Dec 2024 | B-cell non-Hodgkin lymphoma | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C752 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06210243 ↗ |
| Modality | Cell therapy | “C752 CAR-T Cells” NCT06210243 ↗ |